Mindfulness-Based Cognitive Therapy

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved mindfulness scores in surgical PGY-1 residents compared to active controls at both post-intervention and 50-week follow-up, with large effect sizes.

Effect: improvement; Cohen d = 1.03 (post), Cohen d = 0.78 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)

ESRT-1 significantly improved executive cognitive function at 50-week follow-up in surgical PGY-1 residents compared to active controls, with a large effect size.

Effect: improvement; Cohen d = 0.89 (50-wk)